全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Neurons are the Primary Target Cell for the Brain-Tropic Intracellular Parasite Toxoplasma gondii

DOI: 10.1371/journal.ppat.1005447

Full-Text   Cite this paper   Add to My Lib

Abstract:

Toxoplasma gondii, a common brain-tropic parasite, is capable of infecting most nucleated cells, including astrocytes and neurons, in vitro. Yet, in vivo, Toxoplasma is primarily found in neurons. In vitro data showing that interferon-γ-stimulated astrocytes, but not neurons, clear intracellular parasites suggest that neurons alone are persistently infected in vivo because they lack the ability to clear intracellular parasites. Here we test this theory by using a novel Toxoplasma-mouse model capable of marking and tracking host cells that directly interact with parasites, even if the interaction is transient. Remarkably, we find that Toxoplasma shows a strong predilection for interacting with neurons throughout CNS infection. This predilection remains in the setting of IFN-γ depletion; infection with parasites resistant to the major mechanism by which murine astrocytes clear parasites; or when directly injecting parasites into the brain. These findings, in combination with prior work, strongly suggest that neurons are not incidentally infected, but rather they are Toxoplasma’s primary in vivo target.

References

[1]  Porter SB, Sande MA. Toxoplasmosis of the Central Nervous System in the Acquired Immunodeficiency Syndrome. N Engl J Med. 1992;327: 1643–1648. doi: 10.1056/NEJM199212033272306. pmid:1359410
[2]  Mele A, Paterson PJ, Prentice HG, Leoni P, Kibbler CC. Toxoplasmosis in bone marrow transplantation: a report of two cases and systematic review of the literature. Bone Marrow Transplant. 2002;29: 691–698. doi: 10.1038/sj.bmt.1703425. pmid:12180115
[3]  Bernardo DR, Chahin N. Toxoplasmic encephalitis during mycophenolate mofetil immunotherapy of neuromuscular disease. Neurol—Neuroimmunol Neuroinflammation. 2015;2: e63. doi: 10.1212/NXI.0000000000000063.
[4]  Luft BJ, Remington JS. Toxoplasmic encephalitis in AIDS. Clin Infect Dis Off Publ Infect Dis Soc Am. 1992;15: 211–222.
[5]  Antinori A, Larussa D, Cingolani A, Lorenzini P, Bossolasco S, Finazzi MG, et al. Prevalence, associated factors, and prognostic determinants of AIDS-related toxoplasmic encephalitis in the era of advanced highly active antiretroviral therapy. Clin Infect Dis Off Publ Infect Dis Soc Am. 2004;39: 1681–1691. doi: 10.1086/424877.
[6]  Young JD, McGwire BS. Infliximab and reactivation of cerebral toxoplasmosis. N Engl J Med. 2005;353: 1530–1531; discussion 1530–1531. doi: 10.1056/NEJMc051556. pmid:16207863
[7]  Kiderlen TR, Liesenfeld O, Schürmann D, Schneider T. Toxoplasmic encephalitis in AIDS-patients before and after the introduction of highly active antiretroviral therapy (HAART). Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol. 2011;30: 1521–1525. doi: 10.1007/s10096-011-1254-6.
[8]  Remington JS, Cavanaugh EN. Isolation of the encysted form of Toxoplasma gondii from human skeletal muscle and brain. N Engl J Med. 1965;273: 1308–1310. doi: 10.1056/NEJM196512092732404. pmid:5852454
[9]  Dubey JP. Toxoplasmosis of Animals and Humans, Second Edition. CRC Press; 2009.
[10]  Halonen SK, Lyman WD, Chiu FC. Growth and development of Toxoplasma gondii in human neurons and astrocytes. J Neuropathol Exp Neurol. 1996;55: 1150–1156. pmid:8939198 doi: 10.1097/00005072-199611000-00006
[11]  Fischer HG, Nitzgen B, Reichmann G, Gross U, Hadding U. Host cells of Toxoplasma gondii encystation in infected primary culture from mouse brain. Parasitol Res. 1997;83: 637–641. pmid:9272550 doi: 10.1007/s004360050311
[12]  Lüder CGK, Giraldo-Velásquez M, Sendtner M, Gross U. Toxoplasma gondii in Primary Rat CNS Cells: Differential Contribution of Neurons, Astrocytes, and Microglial Cells for the Intracerebral Development and Stage Differentiation. Exp Parasitol. 1999;93: 23–32. doi: 10.1006/expr.1999.4421. pmid:10464035
[13]  Ferguson DJ, Hutchison WM. The host-parasite relationship of Toxoplasma gondii in the brains of chronically infected mice. Virchows Arch A Pathol Anat Histopathol. 1987;411: 39–43. pmid:3107207 doi: 10.1007/bf00734512
[14]  Ferguson DJ, Hutchison WM. An ultrastructural study of the early development and tissue cyst formation of Toxoplasma gondii in the brains of mice. Parasitol Res. 1987;73: 483–491. pmid:3422976 doi: 10.1007/bf00535321
[15]  Melzer TC, Cranston HJ, Weiss LM, Halonen SK. Host Cell Preference of Toxoplasma gondii Cysts in Murine Brain: A Confocal Study. J Neuroparasitology. 2010;1. doi: 10.4303/jnp/N100505.
[16]  Suzuki Y, Orellana MA, Schreiber RD, Remington JS. Interferon-gamma: the major mediator of resistance against Toxoplasma gondii. Science. 1988;240: 516–518. pmid:3128869 doi: 10.1126/science.3128869
[17]  Suzuki Y, Conley FK, Remington JS. Importance of endogenous IFN-gamma for prevention of toxoplasmic encephalitis in mice. J Immunol. 1989;143: 2045–2050. pmid:2506275
[18]  Halonen SK, Taylor GA, Weiss LM. Gamma interferon-induced inhibition of Toxoplasma gondii in astrocytes is mediated by IGTP. Infect Immun. 2001;69: 5573–5576. pmid:11500431 doi: 10.1128/iai.69.9.5573-5576.2001
[19]  Schlüter D, Deckert M, Hof H, Frei K. Toxoplasma gondii Infection of Neurons Induces Neuronal Cytokine and Chemokine Production, but Gamma Interferon- and Tumor Necrosis Factor-Stimulated Neurons Fail To Inhibit the Invasion and Growth of T. gondii. Infect Immun. 2001;69: 7889–7893. doi: 10.1128/IAI.69.12.7889-7893.2001. pmid:11705972
[20]  Martens S, Parvanova I, Zerrahn J, Griffiths G, Schell G, Reichmann G, et al. Disruption of Toxoplasma gondii parasitophorous vacuoles by the mouse p47-resistance GTPases. PLoS Pathog. 2005;1: e24. doi: 10.1371/journal.ppat.0010024. pmid:16304607
[21]  Degrandi D, Kravets E, Konermann C, Beuter-Gunia C, Klümpers V, Lahme S, et al. Murine guanylate binding protein 2 (mGBP2) controls Toxoplasma gondii replication. Proc Natl Acad Sci U S A. 2013;110: 294–299. doi: 10.1073/pnas.1205635110. pmid:23248289
[22]  Koshy AA, Fouts AE, Lodoen MB, Alkan O, Blau HM, Boothroyd JC. Toxoplasma secreting Cre recombinase for analysis of host-parasite interactions. Nat Methods. 2010;7: 307–309. doi: 10.1038/nmeth.1438. pmid:20208532
[23]  Madisen L, Zwingman TA, Sunkin SM, Oh SW, Zariwala HA, Gu H, et al. A robust and high-throughput Cre reporting and characterization system for the whole mouse brain. Nat Neurosci. 2010;13: 133–140. doi: 10.1038/nn.2467. pmid:20023653
[24]  Koshy AA, Dietrich HK, Christian DA, Melehani JH, Shastri AJ, Hunter CA, et al. Toxoplasma Co-opts Host Cells It Does Not Invade. PLoS Pathog. 2012;8: e1002825. doi: 10.1371/journal.ppat.1002825. pmid:22910631
[25]  Christian DA, Koshy AA, Reuter MA, Betts MR, Boothroyd JC, Hunter CA. The use of transgenic parasites and host reporters to dissect the events that promote IL-12 production during toxoplasmosis. Infect Immun. 2014; doi: 10.1128/IAI.01643-14.
[26]  Courret N, Darche S, Sonigo P, Milon G, Buzoni-Gatel D, Tardieux I. CD11c- and CD11b-expressing mouse leukocytes transport single Toxoplasma gondii tachyzoites to the brain. Blood. 2006;107: 309–316. doi: 10.1182/blood-2005-02-0666. pmid:16051744
[27]  Kim S-K, Karasov A, Boothroyd JC. Bradyzoite-specific surface antigen SRS9 plays a role in maintaining Toxoplasma gondii persistence in the brain and in host control of parasite replication in the intestine. Infect Immun. 2007;75: 1626–1634. doi: 10.1128/IAI.01862-06. pmid:17261600
[28]  Emsley JG, Macklis JD. Astroglial heterogeneity closely reflects the neuronal-defined anatomy of the adult murine CNS. Neuron Glia Biol. 2006;2: 175–186. doi: 10.1017/S1740925X06000202. pmid:17356684
[29]  Unal-Cevik I, Kilin? M, Gürsoy-Ozdemir Y, Gurer G, Dalkara T. Loss of NeuN immunoreactivity after cerebral ischemia does not indicate neuronal cell loss: a cautionary note. Brain Res. 2004;1015: 169–174. doi: 10.1016/j.brainres.2004.04.032. pmid:15223381
[30]  Sofroniew MV, Vinters HV. Astrocytes: biology and pathology. Acta Neuropathol (Berl). 2010;119: 7–35. doi: 10.1007/s00401-009-0619-8.
[31]  Gallin JI, Farber JM, Holland SM, Nutman TB. Interferon-γ in the Management of Infectious Diseases. Ann Intern Med. 1995;123: 216–224. doi: 10.7326/0003-4819-123-3-199508010-00009. pmid:7598304
[32]  Bohne W, Heesemann J, Gross U. Induction of bradyzoite-specific Toxoplasma gondii antigens in gamma interferon-treated mouse macrophages. Infect Immun. 1993;61: 1141–1145. pmid:8432596
[33]  Melzer T, Duffy A, Weiss LM, Halonen SK. The Gamma Interferon (IFN-γ)-Inducible GTP-Binding Protein IGTP Is Necessary for Toxoplasma Vacuolar Disruption and Induces Parasite Egression in IFN-γ-Stimulated Astrocytes. Infect Immun. 2008;76: 4883–4894. doi: 10.1128/IAI.01288-07. pmid:18765738
[34]  Zhao YO, Khaminets A, Hunn JP, Howard JC. Disruption of the Toxoplasma gondii Parasitophorous Vacuole by IFNγ-Inducible Immunity-Related GTPases (IRG Proteins) Triggers Necrotic Cell Death. PLoS Pathog. 2009;5: e1000288. doi: 10.1371/journal.ppat.1000288. pmid:19197351
[35]  Fleckenstein MC, Reese ML, K?nen-Waisman S, Boothroyd JC, Howard JC, Steinfeldt T. A Toxoplasma gondii pseudokinase inhibits host IRG resistance proteins. PLoS Biol. 2012;10: e1001358. doi: 10.1371/journal.pbio.1001358. pmid:22802726
[36]  Steinfeldt T, K?nen-Waisman S, Tong L, Pawlowski N, Lamkemeyer T, Sibley LD, et al. Phosphorylation of mouse immunity-related GTPase (IRG) resistance proteins is an evasion strategy for virulent Toxoplasma gondii. PLoS Biol. 2010;8: e1000576. doi: 10.1371/journal.pbio.1000576. pmid:21203588
[37]  Khan A, Taylor S, Ajioka JW, Rosenthal BM, Sibley LD. Selection at a Single Locus Leads to Widespread Expansion of Toxoplasma gondii Lineages That Are Virulent in Mice. PLoS Genet. 2009;5: e1000404. doi: 10.1371/journal.pgen.1000404. pmid:19266027
[38]  Saeij JPJ, Boyle JP, Coller S, Taylor S, Sibley LD, Brooke-Powell ET, et al. Polymorphic secreted kinases are key virulence factors in toxoplasmosis. Science. 2006;314: 1780–1783. doi: 10.1126/science.1133690. pmid:17170306
[39]  Taylor S, Barragan A, Su C, Fux B, Fentress SJ, Tang K, et al. A secreted serine-threonine kinase determines virulence in the eukaryotic pathogen Toxoplasma gondii. Science. 2006;314: 1776–1780. doi: 10.1126/science.1133643. pmid:17170305
[40]  Jones TC, Yeh S, Hirsch JG. The interaction between Toxoplasma gondii and mammalian cells. I. Mechanism of entry and intracellular fate of the parasite. J Exp Med. 1972;136: 1157–1172. pmid:5082671 doi: 10.1084/jem.136.5.1157
[41]  Cekanaviciute E, Dietrich HK, Axtell RC, Williams AM, Egusquiza R, Wai KM, et al. Astrocytic TGF-β Signaling Limits Inflammation and Reduces Neuronal Damage during Central Nervous System Toxoplasma Infection. J Immunol Baltim Md 1950. 2014;193: 139–149. doi: 10.4049/jimmunol.1303284.
[42]  Koshy AA, Cabral CM. 3-D imaging and analysis of neurons infected in vivo with Toxoplasma gondii. J Vis Exp JoVE. 2014; doi: 10.3791/52237.
[43]  H?ndel U, Brunn A, Dr?gemüller K, Müller W, Deckert M, Schlüter D. Neuronal gp130 Expression Is Crucial to Prevent Neuronal Loss, Hyperinflammation, and Lethal Course of Murine Toxoplasma Encephalitis. Am J Pathol. 2012;181: 163–173. doi: 10.1016/j.ajpath.2012.03.029. pmid:22640806
[44]  Portillo J-AC, Okenka G, Reed E, Subauste A, Van Grol J, Gentil K, et al. The CD40-Autophagy Pathway Is Needed for Host Protection Despite IFN-Γ-Dependent Immunity and CD40 Induces Autophagy via Control of P21 Levels. PLoS ONE. 2010;5: e14472. doi: 10.1371/journal.pone.0014472. pmid:21217818
[45]  Grol JV, Muniz-Feliciano L, Portillo J-AC, Bonilha VL, Subauste CS. CD40 Induces Anti-Toxoplasma gondii Activity in Nonhematopoietic Cells Dependent on Autophagy Proteins. Infect Immun. 2013;81: 2002–2011. doi: 10.1128/IAI.01145-12. pmid:23509150
[46]  Hunter CA, Roberts CW, Murray M, Alexander J. Detection of cytokine mRNA in the brains of mice with toxoplasmic encephalitis. Parasite Immunol. 1992;14: 405–413. pmid:1437233 doi: 10.1111/j.1365-3024.1992.tb00015.x
[47]  Lambert H, Vutova PP, Adams WC, Loré K, Barragan A. The Toxoplasma gondii-shuttling function of dendritic cells is linked to the parasite genotype. Infect Immun. 2009;77: 1679–1688. doi: 10.1128/IAI.01289-08. pmid:19204091
[48]  Coombes JL, Charsar BA, Han S-J, Halkias J, Chan SW, Koshy AA, et al. Motile invaded neutrophils in the small intestine of Toxoplasma gondii-infected mice reveal a potential mechanism for parasite spread. Proc Natl Acad Sci U S A. 2013;110: E1913–1922. doi: 10.1073/pnas.1220272110. pmid:23650399
[49]  Stenzel W, Soltek S, Schlüter D, Deckert M. The intermediate filament GFAP is important for the control of experimental murine Staphylococcus aureus-induced brain abscess and Toxoplasma encephalitis. J Neuropathol Exp Neurol. 2004;63: 631–640. pmid:15217091 doi: 10.1093/jnen/63.6.631
[50]  Dr?gemüller K, Helmuth U, Brunn A, Sakowicz-Burkiewicz M, Gutmann DH, Mueller W, et al. Astrocyte gp130 expression is critical for the control of Toxoplasma encephalitis. J Immunol Baltim Md 1950. 2008;181: 2683–2693. doi: 10.4049/jimmunol.181.4.2683
[51]  Murray HW, Hillman JK, Rubin BY, Kelly CD, Jacobs JL, Tyler LW, et al. Patients at risk for AIDS-related opportunistic infections. Clinical manifestations and impaired gamma interferon production. N Engl J Med. 1985;313: 1504–1510. doi: 10.1056/NEJM198512123132403. pmid:3934537
[52]  Lim D, Gold DA, Julien L, Rosowski EE, Niedelman W, Yaffe MB, et al. Structure of the Toxoplasma gondii ROP18 Kinase Domain Reveals a Second Ligand Binding Pocket Required for Acute Virulence. J Biol Chem. 2013;288: 34968–34980. doi: 10.1074/jbc.M113.523266. pmid:24129568

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133